News

Filter

1 to 9 of 96671 results

New drugs could drive celiac disease market to over $550 million by 2023, says analyst

31-10-2014

The launches of Alba/Teva Pharmaceutical Industries’ larazotide acetate and Alvine/AbbVie’s latiglutenase…

AbbVieAlba TherapeuticAlvine PharmaceuticalsEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

Novo Nordisk begins building $130 million lab facility in Denmark

Novo Nordisk begins building $130 million lab facility in Denmark

31-10-2014

Danish insulin giant Novo Nordisk has made a 750 million Danish kroner ($130 million) investment in new…

DenmarkDiabetesNovo NordiskPharmaceuticalProduction

Medivation and Astellas' Xtandi to be market-leader in prostate cancer by 2023

Medivation and Astellas' Xtandi to be market-leader in prostate cancer by 2023

31-10-2014

Xtandi (enzalutamide), produced by biopharma company Medivation and Japanese drug major Astellas Pharma…

AstellasDecision Resources GroupJohnson & JohnsonMarkets & MarketingMedivationOncologyPharmaceuticalXtandiZytiga

Mylan debuts generic Viramune XR in USA

Mylan debuts generic Viramune XR in USA

31-10-2014

US generic drugmaker Mylan said yesterday that it has launched its nevirapine extended-release tablets,…

Anti-viralsBoehringer IngelheimGenericsMarkets & MarketingMylanUSAViramune

US biopharma groups oppose drug disposal ordinance

US biopharma groups oppose drug disposal ordinance

31-10-2014

A coalition of five USA-based health care and drug manufacturing advocacy organizations yesterday expressed…

HealthcarePharmaceuticalRegulationUSA

NICE recommends Pradaxa for DVT and PE

NICE recommends Pradaxa for DVT and PE

31-10-2014

In draft guidance published today, the UK health costs watchdog the National Institute for Health and…

Boehringer IngelheimCardio-vascularPharmaceuticalPradaxaPricingRegulationUK

Teva boosted by generics business to generate sales of $5.06 billion in third-qtr

Teva boosted by generics business to generate sales of $5.06 billion in third-qtr

31-10-2014

Israel-based Teva Pharmaceutical Industries generated sales of $5.06 billion in the third quarter of…

FinancialIsraelPharmaceuticalTevaTeva Pharmaceutical Industries

US FDA approves AstraZeneca’s Xigduo XR

US FDA approves AstraZeneca’s Xigduo XR

30-10-2014

The US Food and Drug Administration has approved Anglo-Swedish pharma major AstraZeneca’s once-daily…

AstraZenecaDiabetesPharmaceuticalRegulationUSAXigduo XR

1 to 9 of 96671 results

Parexel

Parexel

Back to top